Key result
Aripiprazole therapy is linked to late-onset neuroleptic malignant syndrome.
Key points are not available for this paper at this time.
Clinicians should monitor for late-onset NMS with aripiprazole; case report leaves open true incidence and risk factors.
Agrawal, Ankit MD1; Bajaj, Divyansh MD2; Bajaj, Suryansh MBBS3; Mattana, Joseph MD2 Author Information
No takes yet. Share an insight, caveat, or question.
Agrawal et al. (2019) studied this question. Aripiprazole therapy can induce late-onset neuroleptic malignant syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: